Form 8-K - Current report:
SEC Accession No. 0001070081-24-000029
Filing Date
2024-12-02
Accepted
2024-12-02 07:15:10
Documents
16
Period of Report
2024-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20241127x8k.htm   iXBRL 8-K 52635
2 EX-99.1 tmb-20241127xex99d1.htm EX-99.1 36605
3 GRAPHIC tmb-20241127xex99d1002.jpg GRAPHIC 5563
  Complete submission text file 0001070081-24-000029.txt   233103

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20241127.xsd EX-101.SCH 3934
5 EX-101.DEF tmb-20241127_def.xml EX-101.DEF 2806
6 EX-101.LAB tmb-20241127_lab.xml EX-101.LAB 16547
7 EX-101.PRE tmb-20241127_pre.xml EX-101.PRE 9655
18 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20241127x8k_htm.xml XML 4725
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 241517402
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)